2018 Meeting Presentations

Biennial Meeting

The MSGERC 2018 Biennial Meeting “Clinical Mycology Today” was a resounding success!  Experts from around the globe who specialize in fungus and mycoses gathered for 3 full days of plenary talks, falling into 4 broad categories: Aspergillosis, Candida, Cryptococcosis, Endemic Mycoses, plus Gerald McGwin’s groundbreaking keynote presentation, “Biostatistics for Fungal Disease Trials: Special Considerations”.  These sessions were followed by panel and audience interactive discussions.  

The presentation videos and handouts are listed below, click on the green buttons for the links.  Or go straight to the MSGERC YouTube Channel to see all the presentations.  We hope you will view and share them with other scientists, researchers and doctors.  Together, we champion evidence-based diagnoses, prevention, treatment and management of invasive fungal infections.

Keynote Presentation

Biostatistics for Fungal Disease Trials: Special Considerations

Gerald McGwin, Jr., MS, PhD

Professor of Epidemiology and Director of Advanced Enterprise Analytics University of Alabama at Birmingham

Aspergillosis Lectures and Facilitated Discussions

Facilitated by: Marisa Miceli, MD and Dimitrios Kontoyiannis, MD

Aspergillus Diagnostics

Dr P. Lewis White, FECMM, FRCPath

Head of Mycology Reference Laboratory
Public Health Wales, Microbiology Cardiff

Invasive Aspergillosis in 2018: An Update in Diagnosis and Management

Dimitrios P. Kontoyannis, MD, ScD, PhD, FIDSA, FACP, FAAM, FEMM, AAAS

Texas 4,000 Distinguished Endowed Professor
Deputy Head, Division of Internal Medicine
MD Anderson Cancer Center

Insights into Antifungal Resistance & Newer (Other) Mould

Nathan P. Wiederhold, Pharm D

Fungus Testing Laboratory
UT San Antonio

Aspergillus Facilitated Panel Discussion

Patterson, MD FACP, FIDSA

Professor of Medicine
Vice-Chair for Faculty Development
Chief, Division of Infectious Diseases
Director, San Antonio Center for Medical Mycology

What are the Clinical Implications of Antifungal Resistance

Marisa Miceli, MD & Dimitrios Kontoyiannis, MD

Keynote Presentation

Facilitated by: Luis Ostrosky-Zeichner, MD, FACP and Peter Pappas, MD

Updates on Candida Immunology

Michail Lionakis, MD, ScD

Chief, Fungal Pathogenesis Section
National Institute of Allergy & Infectious Diseases

Antifungal Resistance Among Candida spp

David Perlin, PhD

Executive Director and Professor
Rutgers Biomedical and Health Sciences

Updates: Candida Epidemiology and Candida auris

Tom Chiller, MD, MPHTM

Chief, Mycotic Diseases Branch
Centers for Disease Control and Prevention

Candida diagnostics

Cornelius (Neil) Clancy, MD

Chief, Infectious Diseases
VA Pittsburgh Healthcare System

Candida Facilitated Panel Discussion

Luis Ostrosky-Zeichner, MD, FACP and Peter Pappas, MD

Cryptococcus Lectures and Facilitated Discussions

Facilitated by: John Perfect, MD and David Boulware, MD, MPH

Rethinking immunity to Cryptococcus: What about antibody?

Liise-anne Pirofski, MD

Chief, Division of Infectious Diseases
Montefiore Medical Center and Albert Einstein College of Medicine

New Insights into the Pathogenesis of Cryptococcosis: Focus on the Organism

Andy Alspaugh, MD

Duke University School of Medicine

Clinical Trials for Cryptococcosis

David Boulware, MD, MPH

Associate Professor
University of Minnesota

New Treatments for Cryptococcosis

William Hope PhD, FRACP, FRCPA

Professor of Therapeutics and Infectious Diseases
University of Liverpool

Cryptococcal Treatment Guidelines: Experience, Evidence and Controversies

John Perfect, MD

Chief, Division of Infectious Diseases
Duke University Medical Center

Cryptococcus Facilitated Panel Discussion

John Perfect, MD and David Boulware, MD, MPH

Endemic Lectures and Facilitated Discussions

Facilitated by: Andrej Spec, MD and GR Thompson, MD

Genetics, Evolutionary Biology, Environment

John Taylor, PhD

University of California Berkeley, The Taylor Lab

Update on Diagnostics and Treatment

George (GR) Thompson, MD

Associate Professor of Clinical Medicine
University of California, Davis Medical Center

Emerging Dimorphic Fungi: Blastomyces & Emergomyces

Ilan Schwartz,MD, PhD, FRCPC

Assistant Professor
University of Alberta

Histoplasmosis: A Latin American Perspective
Ana Belen Arauz Rodriguez, MD, MSc, FACP Attending Physician / Infectologist Hospital Santo Tomas
Endemic and other Mycoses Facilitated Panel Discussion

Andrej Spec, MD and GR Thompson, MD